title: Terazosin (Hytrin): cumulative experience of clinical trials in the USA for the treatment of mild to moderate essential hypertension.
authors.forename: J L
authors.initials: JL
authors.lastname: Pool
authors.forename: E B
authors.initials: EB
authors.lastname: Nelson
authors.forename: A A
authors.initials: AA
authors.lastname: Taylor
authors.forename: J R
authors.initials: JR
authors.lastname: Mitchell
mesh_terms: D000293:Adolescent; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011224:Prazosin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014481:United States
chemical_list: D000317:Adrenergic alpha-Antagonists; C041226:Terazosin; D011224:Prazosin